Newsroom

Sorted by: Latest

-

Riassunto: BeOne Medicines, BeOne Care Foundation e The Max Foundation rinnovano la collaborazione per ampliare l'accesso a BRUKINSA® per il trattamento della leucemia linfatica cronica nei Paesi a reddito medio-basso

SAN CARLOS, Calif. e SEATTLE--(BUSINESS WIRE)--BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), azienda multinazionale operante nel settore dell'oncologia, in collaborazione con la BeOne Care Foundation, una fondazione benefica no-profit, e The Max Foundation, importante ente sanitario internazionale non a scopo di lucro, oggi hanno annunciato di aver rinnovato la collaborazione fino al 2028 per estendere l'accesso a BRUKINSA® (zanubrutinib) per il trattamento della leuce...
-

Lehman Brothers Treasury Announces the Successful Sale of its Remaining Intercompany Claim against Lehman Brothers Holdings Inc.

AMSTERDAM--(BUSINESS WIRE)--In connection with its previously announced final wind-down, Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”), through its U.S. counsel Herbert Smith Freehills Kramer (US) LLP, announced that its placement agent, Seaport Loan Products LLC, successfully closed the sale of LBT’s remaining $19.6 billion Class 4A intercompany claim against Lehman Brothers Holdings Inc. The net proceeds of the sale, together with certain available cash (but after deducting various...
-

グラディアント、新たな経営陣の就任、拠点開設、長期サービス契約により米国事業を拡大

ボストン--(BUSINESS WIRE)--(ビジネスワイヤ) -- マイクロチップ、データセンター、そしてメガワット単位のAI処理能力はすべて、水に支えられています。「AI経済の水の基盤」を担うグラディアントは、米国全土におけるこの水資源の制約を解決する能力を強化する一連の重要な進展を発表しました。具体的には、米国事業の新リーダーの任命、3つの新オフィスと新たなイノベーションセンターの開設、そして大手半導体メーカーとの契約を含む長期サービス契約の締結です。 グラディアントは、米州地域における成長の勢いを加速させるため、ニッシュ・ヴォラを米州担当マネージング・ディレクターに任命しました。ヴォラは、GEウォーター、スエズ・ウォーター・テクノロジーズ、そして直近ではベオリア・ウォーター・テクノロジーズ・アンド・ソリューションズといった企業で上級管理職を歴任してきた、実績ある成長のリーダーです。技術面および事業面におけるリーダーシップは、「顧客のためにスピード感を持ってイノベーションを推進する」というグラディアントの企業文化に合致しています。この任命に加え、フェニックス、シラキュース、フ...
-

Greenstone Biosciences Awarded Breakthrough T1D Grant to Advance Islet Cell Platform

PALO ALTO, Calif.--(BUSINESS WIRE)--Greenstone Biosciences has been awarded a Breakthrough T1D Industry Discovery and Development Partnership (IDDP) grant to develop a T1D-derived islet cell platform aimed at understanding and protecting insulin-producing β cells in people with type 1 diabetes.Over 9.5 million people globally live with T1D, expected to rise to 14.7 million by 2040. Although T1D stems from an autoimmune attack on the pancreas, it shows significant variation among individuals, eve...
-

BeOne Medicines, BeOne Care Foundation y The Max Foundation renuevan la alianza para ampliar el acceso a BRUKINSA® para el tratamiento de la leucemia linfocítica crónica en países de ingresos bajos y medios

SAN CARLOS, California y SEATTLE--(BUSINESS WIRE)--BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), empresa oncológica internacional, junto con BeOne Care Foundation, organización de beneficencia sin fines de lucro, y The Max Foundation, organización global sin fines de lucro líder en el ámbito de la salud, anunciaron hoy la renovación de su alianza hasta 2028 para ampliar el acceso a BRUKINSA® (zanubrutinib) para el tratamiento de la leucemia linfocítica crónica (LLC) en...
-

Kessler Topaz Meltzer & Check, LLP Files a Class Action Lawsuit Against Volkswagen for Selling Vehicles With Defective Batteries that Catch Fire

RADNOR, Pa.--(BUSINESS WIRE)--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized class action litigation law firm, has filed a class action lawsuit against Volkswagen Aktiengesellschaft and Volkswagen Group of America, Inc. (“VW”), for breach of express warranty and other federal and state law violations. The complaint alleges that VW manufactured and sold certain vehicles – 2023-2025 Volkswagen ID.4s – which have defective batteries that may suddenly and unexpectedl...
-

Gradiant amplia le operazioni statunitensi con una nuova leadership, l'apertura di nuove sedi e contratti a lungo termine per la fornitura di servizi

BOSTON--(BUSINESS WIRE)--Ogni microchip, data center e megawatt di capacità dell'intelligenza artificiale dipende dall'acqua. Oggi Gradiant, la componente idrica dell'economia legata all'IA, ha annunciato una serie di tappe per rafforzare la sua capacità di superare tale limite negli Stati Uniti: una nuova assunzione ai vertici statunitensi della società, tre nuove sedi, un centro di innovazioni e contratti a lungo termine per la fornitura di servizi, tra cui uno con un grande produttore di chi...
-

Riassunto: GenBio AI sviluppa il primo modello di mondo della cellula umana

PALO ALTO, California--(BUSINESS WIRE)--GenBio AI ("GenBio") è una società specializzata in IA per uso scientifico, cofondata dal premio Nobel David Baker, dallo scienziato leader in ambito IA Eric Xing e da altri importanti ricercatori nei settori di scienze della vita e IA provenienti da Stanford, Carnegie Mellon University, Mohamed Bin Zayed University of Artificial Intelligence, Harvard, Weizmann Institute e da altri istituti di ricerca. Oggi l'azienda ha presentato AIDO Cell, il suo modell...
-

Samenvatting: GenBio AI ontwikkelt het eerste wereldmodel van de menselijke cel

PALO ALTO, Calif.--(BUSINESS WIRE)--GenBio AI ('GenBio') is een 'AI for Science'-bedrijf dat mede is opgericht door Nobelprijswinnaar David Baker, vooraanstaand AI-wetenschapper Eric Xing en andere prominente onderzoekers op het gebied van levenswetenschappen en kunstmatige intelligentie. Zij zijn afkomstig van instellingen als Stanford, Carnegie Mellon University, Mohamed Bin Zayed University of Artificial Intelligence, Harvard, het Weizmann Institute en andere onderzoeksinstellingen. Vandaag...
-

Hagens Berman: Consumers Seek Final Approval for Injunctive Settlement with Agri Stats in Massive Chicken Antitrust Class-Action Lawsuit

CHICAGO--(BUSINESS WIRE)--A class of hundreds of millions of consumers seeks approval of a settlement in a lawsuit against chicken producers, according to Hagens Berman....